Cargando…
Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
PURPOSE: Lymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC. METHODS: The clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394766/ https://www.ncbi.nlm.nih.gov/pubmed/29876836 http://dx.doi.org/10.1007/s40618-018-0908-y |
_version_ | 1783398965192949760 |
---|---|
author | Luo, Y. Zhao, Y. Chen, K. Shen, J. Shi, J. Lu, S. Lei, J. Li, Z. Luo, D. |
author_facet | Luo, Y. Zhao, Y. Chen, K. Shen, J. Shi, J. Lu, S. Lei, J. Li, Z. Luo, D. |
author_sort | Luo, Y. |
collection | PubMed |
description | PURPOSE: Lymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC. METHODS: The clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate and multivariate analyses were used to identify risk factors associated with cervical lymph node metastasis. ROC analysis was used to determine the ideal critical points of the sum of the maximum diameter of multifocal in a unilateral lobe. RESULTS: The probability of LNM, central lymph node metastasis (CLNM) and lateral lymph node metastasis(LLNM)of PTMC patients were 35.6, 33.7 and 5.6%, respectively. In addition, 1.9% PTMC had LLNM only. Male, age ≤ 40 years, tumor largest diameter ≥ 5 mm, multifocal, non-uniform echoic distribution, the sum of the maximum diameter of multifocal in a unilateral lobe ≥ 8.5 mm, tumors in the lower pole location were prone to CLNM. Ultrasound mix-echo, the sum of the maximum diameter of the multifocal ≥ 10.75 mm, tumors in the upper pole location were extremely prone to LLNM. T3 were prone to LLNM or skip LLNM. CONCLUSIONS: According to the clinicopathological characteristics of PTMC, the cervical lymph nodes should be correctly evaluated to guide the surgical treatment. |
format | Online Article Text |
id | pubmed-6394766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-63947662019-03-15 Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma Luo, Y. Zhao, Y. Chen, K. Shen, J. Shi, J. Lu, S. Lei, J. Li, Z. Luo, D. J Endocrinol Invest Original Article PURPOSE: Lymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC. METHODS: The clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate and multivariate analyses were used to identify risk factors associated with cervical lymph node metastasis. ROC analysis was used to determine the ideal critical points of the sum of the maximum diameter of multifocal in a unilateral lobe. RESULTS: The probability of LNM, central lymph node metastasis (CLNM) and lateral lymph node metastasis(LLNM)of PTMC patients were 35.6, 33.7 and 5.6%, respectively. In addition, 1.9% PTMC had LLNM only. Male, age ≤ 40 years, tumor largest diameter ≥ 5 mm, multifocal, non-uniform echoic distribution, the sum of the maximum diameter of multifocal in a unilateral lobe ≥ 8.5 mm, tumors in the lower pole location were prone to CLNM. Ultrasound mix-echo, the sum of the maximum diameter of the multifocal ≥ 10.75 mm, tumors in the upper pole location were extremely prone to LLNM. T3 were prone to LLNM or skip LLNM. CONCLUSIONS: According to the clinicopathological characteristics of PTMC, the cervical lymph nodes should be correctly evaluated to guide the surgical treatment. Springer International Publishing 2018-06-06 2019 /pmc/articles/PMC6394766/ /pubmed/29876836 http://dx.doi.org/10.1007/s40618-018-0908-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Luo, Y. Zhao, Y. Chen, K. Shen, J. Shi, J. Lu, S. Lei, J. Li, Z. Luo, D. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
title | Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
title_full | Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
title_fullStr | Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
title_full_unstemmed | Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
title_short | Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
title_sort | clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394766/ https://www.ncbi.nlm.nih.gov/pubmed/29876836 http://dx.doi.org/10.1007/s40618-018-0908-y |
work_keys_str_mv | AT luoy clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT zhaoy clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT chenk clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT shenj clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT shij clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT lus clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT leij clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT liz clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma AT luod clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma |